Fecal Microbiota Transplantation: KF2022#1 Trial

We are investigating how fecal microbiota transplantation may affect enzyme activities in the body. This study aims to understand its potential benefits for patients with certain health conditions.

>2 yearsSafety phase (I)GastroenterologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
HUS-Yhtymae
HUS Diagnostic Center, Clinical Pharmacology
Helsinki, Finland
Sponsor: HUS-Yhtymae
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.